Hillstream BioPharma, Inc.
Hillstream BioPharma, Inc. (HILS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
hils · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Hillstream BioPharma, Inc. (HILS) measures how much investors pay for each dollar of the company's trailing earnings. HILS's current PE ratio of N/A is calculated by dividing its stock price of $0.24 by its TTM earnings per share of -$0.39.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Hillstream BioPharma, Inc.You HILS | $4M | N/A | — | -$0.39 |
 Aptose Biosciences Inc. APTO | $4M | N/A | — | $0.00 |
 Atreca, Inc. BCEL | $4M | N/A | — | -$2.52 |
 Altamira Therapeutics Ltd. CYTO | $1M | N/A | — | $0.00 |
 Gamida Cell Ltd. GMDA | $4M | N/A | — | -$0.42 |
 Gritstone bio, Inc. GRTS | $4M | N/A | — | -$1.20 |
 Nabriva Therapeutics plc NBRVF | $0M | N/A | — | -$21.32 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.12 | — | |
2024-12-31 FY2024 | — | $-9.41 | — | |
2023-12-31 FY2023 | — | $-7.14 | — | |
2022-12-31 FY2022 | — | $-0.75 | — | |
2021-12-31 FY2021 | — | $-0.30 | — | |
2020-12-31 FY2020 | — | $-0.21 | — | |
2019-12-31 FY2019 | — | $-0.10 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Hillstream BioPharma, Inc. (HILS) measures how much investors pay for each dollar of the company's trailing earnings. HILS's current PE ratio of N/A is calculated by dividing its stock price of $0.24 by its TTM earnings per share of -$0.39.
Frequently asked questions
HILS pe ratio · 6 questionsHILS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.24 and TTM EPS of -$0.39. Data sourced from Financial Modeling Prep via HILS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Hillstream BioPharma, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09